Status:
COMPLETED
Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure
Lead Sponsor:
Hôpital de Verdun
Conditions:
Respiratory Failure
Respiratory Insufficiency
Eligibility:
All Genders
18+ years
Brief Summary
A retrospective cohort study of all patients treated for type II (hypercapnic) respiratory failure with either High-Flow Oxygen Therapy or Non-Invasive Ventilation in a general adult hospital.
Detailed Description
We will compare various clinically relevant outcomes in patients treated for type II (hypercapnic) acute respiratory failure (ARF) with either High-Flow Nasal Cannula (HFNC) or Non-Invasive Ventilatio...
Eligibility Criteria
Inclusion
- All patients treated with respiratory failure not responding to conventional supplemental oxygen therapy
- Blood venous gas showing partial pressure of carbon dioxide\>50 mmHg before beginning therapy with either NIV or HFNC
Exclusion
- Lack of records of the primary outcome
- End-of-life care
- Lack of gas before the beginning of NIV or HFNC
Key Trial Info
Start Date :
April 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
324 Patients enrolled
Trial Details
Trial ID
NCT03443479
Start Date
April 1 2015
End Date
July 1 2019
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de Verdun
Montreal, Quebec, Canada, H4G2A2